<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>a2100203zex-2_1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03HOU1017_2">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kc1017_exhibit_2.1_(iv)"> </A>
<A NAME="toc_kc1017_1"> </A>
<BR></FONT><FONT SIZE=2><B>EXHIBIT&nbsp;2.1 (iv)    <BR>  </B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>Information Deleted Pursuant To A Request For Confidential Treatment<BR>
Is Indicated By [***]</B></FONT></P>

<BR>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>ASSET PURCHASE AGREEMENT  </B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>BETWEEN  </B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>BOEHRINGER INGELHEIM VETMEDICA,&nbsp;INC.  </B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>AND  </B></FONT></P>

<BR>
<P ALIGN="CENTER"><FONT SIZE=2><B>KMG BERNUTH,&nbsp;INC.  </B></FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=934218,FOLIO='blank',FILE='DISK012:[03HOU7.03HOU1017]KC1017A.;5',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="page_ke1017_1_2"> </A> </FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ke1017_table_of_contents"> </A>
<A NAME="toc_ke1017_1"> </A>
<BR></FONT><FONT SIZE=2><B>TABLE OF CONTENTS    <BR>  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B>ARTICLE 1 DEFINITIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>1</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 2 PURCHASE AND SALE OF ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
4</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>2.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>PURCHASED ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>4</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>2.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>EXCLUDED ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>4</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>2.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ASSUMED LIABILITIES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>4</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>2.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>LIMITATION OF LIABILITIES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>5</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>2.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>DELIVERY</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 3 PURCHASE PRICE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
7</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>3.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>CONSIDERATION FOR THE PURCHASED ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>3.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ALLOCATION OF PURCHASE PRICE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>3.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>CERTAIN PRO-RATIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 4 CLOSING</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
7</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>4.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>CLOSING</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>4.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>DELIVERIES BY THE SELLER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>7</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>4.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>DELIVERIES BY THE BUYER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>8</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF THE SELLER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
9</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ORGANIZATION AND EXISTENCE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>9</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>AUTHORITY</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>9</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NO VIOLATIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>9</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>GOVERNMENTAL APPROVAL</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>9</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SELLER PROCEEDINGS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>9</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.6</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NO BROKERS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>10</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.7</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>OWNERSHIP OF PURCHASED ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>10</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.8</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ENVIRONMENTAL MATTERS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>11</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.9</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>COMPLIANCE WITH LAWS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>12</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.10</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>PERMITS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>12</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.11</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>FINANCIAL STATEMENTS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>13</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.12</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>INTANGIBLE ASSETS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>13</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.13</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>INSTRUMENTS IN FULL FORCE AND EFFECT</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>13</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>5.14</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>DISCLAIMER OF OTHER REPRESENTATIONS AND WARRANTIES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>13</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 6 REPRESENTATIONS AND WARRANTIES OF THE BUYER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
14</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ORGANIZATION AND EXISTENCE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>14</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>AUTHORITY</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>14</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NO VIOLATIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>14</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>GOVERNMENTAL APPROVAL</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>14</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>BUYER PROCEEDINGS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>14</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>6.6</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NO BROKERS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>15</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 7 POST CLOSING COVENANTS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
15</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>CONFIDENTIALITY</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>15</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>EXPENSES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>15</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>AGREEMENT TO NOT COMPETE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>15</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NON-INTERFERENCE WITH RELATIONSHIPS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>16</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SPECIFIC PERFORMANCE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>16</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.6</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>TESTING COSTS REIMBURSEMENT</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>16</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.7</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SUBREGISTRATIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>16</B></FONT></TD>
</TR>
</TABLE>
<!-- insert table folio -->
<P ALIGN="CENTER"><FONT SIZE=2>ii</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=2,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=1034924,FOLIO='ii',FILE='DISK012:[03HOU7.03HOU1017]KE1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ke1017_1_3"> </A>
<!-- end of table folio -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.8</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>DIFLUBENZURON AGREEMENT</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>16</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>7.9</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>TRADEMARK LICENSE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>17</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 8 EXTENT AND SURVIVAL OF REPRESENTATIONS, WARRANTIES, COVENANTS AND AGREEMENTS; INDEMNIFICATION</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
17</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>INDEMNIFICATION BY THE SELLER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>17</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>INDEMNIFICATION BY THE BUYER</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>17</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>INDEMNIFICATION PROCEDURE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>17</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SURVIVAL</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>APPLICABILITY OF INDEMNIFICATION OBLIGATION</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.6</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>LIMITATION ON AMOUNTS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.7</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>EFFECT OF INSURANCE</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>8.8</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SOLE REMEDY</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD COLSPAN=5><FONT SIZE=2><B><BR>
ARTICLE 9 MISCELLANEOUS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><B><BR>&nbsp;</B></FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B><BR>
18</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.1</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>NOTICES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>18</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.2</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>ENTIRE AGREEMENT</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>19</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.3</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>AMENDMENTS AND WAIVER; RIGHTS AND REMEDIES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>19</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.4</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>GOVERNING LAW</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>20</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.5</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>BINDING EFFECT; ASSIGNMENT</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>20</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.6</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>COUNTERPARTS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>20</B></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.7</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>REFERENCES</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>20</B></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="2%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2><B>9.8</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="80%"><FONT SIZE=2><B>SEVERABILITY OF PROVISIONS</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><B>20</B></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<BR>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="49%" ALIGN="LEFT"><FONT SIZE=1><B>Schedules<BR> </B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="49%" ALIGN="LEFT"><FONT SIZE=1><B>Exhibits<BR> </B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;2.1: Purchased Assets</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;A: General Conveyance</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;2.2: Excluded Assets</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;B: Assumption Agreement</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;2.3: Ordinary Course Agreements</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>Exhibit&nbsp;C: Registration Assignment</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;3.2: Allocation of Purchase Price</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;D: Contract Manufacturing Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;3.3: Certain Pro-Rations</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;E: Matters for Seller's Opinion</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.4: Governmental Approvals</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;F: Matters for Buyer's Opinion</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.5(a): Proceedings</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;G: Subregistration Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.5(b): Orders</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;H: Assignment and Assumption Agreement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.7(a): Title to Assets</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>Exhibit&nbsp;I: Subordination Agreement</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.7(b): Other Excluded Assets</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>Exhibit&nbsp;J: Hartz Consent</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.8(a): Environmental Matters</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>Exhibit&nbsp;K: Guaranty</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.8(c): Environmental Matters</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.8(d): Environmental Matters</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="TOP"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.10: Permits</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.11(b): Certain Events</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2>Schedule&nbsp;5.12: Proprietary Rights</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>iii</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=3,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=5714,FOLIO='iii',FILE='DISK012:[03HOU7.03HOU1017]KE1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kg1017_asset_purchase_agreement"> </A>
<A NAME="toc_kg1017_1"> </A>
<BR></FONT><FONT SIZE=2><B>ASSET PURCHASE AGREEMENT    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This ASSET PURCHASE AGREEMENT ("this Agreement") is entered into on and effective as of this 30th day of December, 2002, by and between BOEHRINGER INGELHEIM
VETMEDICA,&nbsp;INC., a Delaware corporation (the "Seller"), and KMG BERNUTH,&nbsp;INC., a Delaware corporation (the "Buyer"). Seller and Buyer are each a "party" hereunder and collectively the
"parties" hereunder. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>RECITALS  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Seller desires to transfer to the Buyer certain of the properties, assets and liabilities related to the Business (as defined below), and the Buyer
desires to acquire such properties, assets and liabilities, all upon the terms set forth herein; and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
the parties hereto desire to set forth certain representations, warranties and agreements, all as more fully set forth below; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW,
THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as
follows: </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kg1017_article_1_definitions"> </A>
<A NAME="toc_kg1017_2"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 1<BR>  DEFINITIONS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this Agreement, the following terms have the following respective meanings: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Accounts
Receivable" means (a)&nbsp;all trade accounts receivable and other rights to payment from customers of Seller, (b)&nbsp;all other accounts and notes receivable and
(c)&nbsp;any claim, remedy, security interest, lien, or other right related to any of the foregoing. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Affiliate"
means, as to the Person specified, any Person controlling, controlled by or under common control with such Person, with the concept of control in such context meaning the
possession, directly
or indirectly, of the power to direct or cause the direction of the management and policies of another, whether through the ownership of voting securities, by contract or otherwise. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Agreement"
has the meaning specified in the opening paragraph. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Applicable
Environmental Laws" has the meaning specified in Section&nbsp;5.8(f). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Assumed
Liabilities" has the meaning specified in Section&nbsp;2.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Assumption
Agreement" has the meaning specified in Section&nbsp;4.2(d). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Business"
shall mean the manufacturing, processing, storing, distributing, selling, marketing, use and licensing of the Rabon Products. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Buyer"
means KMG Bernuth,&nbsp;Inc., a Texas corporation. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Buyer's
Liabilities" means all liabilities of the Buyer fixed, contingent or otherwise, including any liabilities (i)&nbsp;related to the ownership, management or use of the Purchased
Assets or operation of the Business after the Closing; and (ii)&nbsp;all Assumed Liabilities; but, exclusive of the Retained Liabilities. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Claims"
means all losses, liabilities, claims, demands, damages, costs and expenses (including reasonable attorneys' fees and disbursements) of every kind, nature and description. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Closing"
has the meaning specified in Section&nbsp;4.1. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Common
Records" means, exclusive of the Rabon Records, all Records in possession of the Seller, to the extent that such Records relate, directly or indirectly, in whole or in part, to
the Business, the Purchased Assets of the Assumed Liabilities and shall include historical financial and tax records related to the prior operation of the Business. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Confidential
Information" has the meaning specified in Section&nbsp;7.1. </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=4,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=344324,FOLIO='blank',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kg1017_1_2"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Contract
Manufacturing Agreement" has the meaning specified in Section&nbsp;4.2(e). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Encumbrances"
means liens, charges, pledges, options, mortgages, security interests, claims, easements, rights-of-way, servitudes, title defects, rights of third
parties and other encumbrances of every type and description, whether imposed by law, agreement, understanding or otherwise. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"EPA"
means the United States Environmental Protection Agency and all subdivisions thereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Excluded
Assets" has the meaning specified in Section&nbsp;2.2. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Facility"
means the Seller's manufacturing facility in Elwood, Kansas. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Finished
Rabon Inventory" has the meaning specified in Section&nbsp;2.2. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"General
Conveyance" has the meaning specified in Section&nbsp;4.2(d). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Governmental
Entity" means any court or tribunal in any jurisdiction (domestic or foreign) or any public, governmental or regulatory body, agency, department, commission, board, bureau
or other authority or instrumentality (domestic or foreign). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Hazardous
Material" has the meaning specified in Section&nbsp;5.8(f). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Hartz
Consent" has the meaning specified in Section&nbsp;4.2(h). </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Indemnified
Party" has the meaning specified in Section&nbsp;8.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Indemnifying
Party" has the meaning specified in Section&nbsp;8.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Instruments"
has the meaning specified in Section&nbsp;5.13. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Knowledge"
with respect to either party means the actual knowledge after reasonable inquiry of the executive management of such party and any other Person with direct supervisory
responsibility over a matter for such party. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Legal
Requirements" has the meaning specified in Section&nbsp;5.9(a). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Marks"
has the meaning specified in Section&nbsp;5.7(b)(3). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Non-Compete
Term" has the meaning specified in Section&nbsp;7.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Ordinary
Course Agreements" has the meaning specified in Section&nbsp;2.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Permits"
means any permit, approval, authorization, license, variance, or other permission or consent required from a Governmental Entity under any applicable Legal Requirement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Permitted
Encumbrances" means Encumbrances for taxes, assessments and governmental charges not yet due and payable or the validity of which are being contested in good faith by
appropriate proceedings. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Person"
shall mean a corporation, an association, a partnership, an organization, a business, an individual or a Governmental Entity. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Proceedings"
means all proceedings, arbitration, litigation, actions, claims, suits, investigations and inquiries by or before any arbitrator or Governmental Entity. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Proprietary
Rights" has the meaning specified in Section&nbsp;5.7(b)(3). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Purchased
Assets" has the meaning specified in Section&nbsp;2.1. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Purchase
Price" has the meaning specified in Section&nbsp;3.1. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=5,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=417520,FOLIO='2',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kg1017_1_3"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Rabon
Products" means the Rabon&#153; and Ravap&#153; product lines, which consists solely of the following products: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE WIDTH="65%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="82%" ALIGN="LEFT"><FONT SIZE=1><B>PRODUCT NAME:<BR> </B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="15%" ALIGN="CENTER"><FONT SIZE=1><B>EPA Reg. No.</B></FONT><HR NOSHADE></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon 50 WP Insecticide</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-128</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>75% Rabon Insecticide Wettable Powder</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-129</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon 3 Insecticide Dust</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-131</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon E.C. Livestock, Poultry and Premise Insecticide</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-132</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon 97.3 Oral Larvicide</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-133</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon 7.76 Oral Larvicide Premix</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-134</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Rabon Oral Larvicide Manufacturing Base</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-135</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Ravap E.C. Livestock, Poultry &amp; Premise Insecticide Spray</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-136</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Tick &amp; Flea Sponge-on for Dogs and Cats</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-139</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Technical Rabon Insecticide</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-149</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Americare Rabon Flea &amp; Tick Collar for Dogs</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-150</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="82%"><FONT SIZE=2>Americare Rabon Flea &amp; Tick Collar for Cats</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="15%" ALIGN="CENTER"><FONT SIZE=2>4691-151</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Rabon
Records" means all Records directly and solely related to the Business, the Purchased Assets, or the Assumed Liabilities. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Ravap
Products" means the Ravap E.C. Livestock, Poultry&nbsp;&amp; Premise Insecticide Spray. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Real
Property" means (i)&nbsp;all land in which Seller has an ownership interest, (ii)&nbsp;all buildings, structures, fixtures, and improvements located on such land, including
those under construction, and (iii)&nbsp;means all privileges, rights, easements, and appurtenances belonging to or for the benefit of such land. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Records"
means all information, regardless of the medium, including, but not limited to: schedules, work papers, books, records, notes, sales and sales promotional data, advertising
materials, credit information, cost and pricing information, equipment maintenance data, purchasing records and information, supplier lists, business plans, reference catalogs, purchase orders, sales
forms, labels, catalogs, brochures, artwork, photographs, product display and other similar property, rights and information. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Retained
Liabilities" has the meaning specified in Section&nbsp;2.4. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Seller"
means Boehringer Ingelheim Vetmedica,&nbsp;Inc., a Delaware corporation. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Seller
Financial Statements" has the meaning specified in Section&nbsp;5.11. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Seller's
Liabilities" means all liabilities of the Seller fixed, contingent or otherwise, including any liabilities (i)&nbsp;related to the ownership, management or use of the
Purchased Assets or operation of the Business prior to the Closing; and (ii)&nbsp;all Retained Liabilities; but, exclusive of the Assumed Liabilities. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Seller
MAE" means a single event, occurrence or fact that, together with all other events, occurrences and facts that (i)&nbsp;has had or will have (x)&nbsp;a material adverse
effect on the Business or Purchased Assets or (y)&nbsp;a material adverse effect on the ability of the Buyer to operate the Business after the date of Closing, (ii)&nbsp;would create an
Encumbrance on any of the Purchased Assets except for a Permitted Encumbrance, (iii)&nbsp;results in a loss or damage to the Purchased Assets (whether or not covered by
insurance) in an amount in excess of $10,000.00 or (iv)&nbsp;may constitute a criminal violation of law involving a felony. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Subordination
Agreement" has the meaning specified in Section&nbsp;4.2(g). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Subregistration
Agreement" has the meaning specified in Section&nbsp;7.7. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=6,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=948902,FOLIO='3',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kg1017_1_4"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"TCVP
Task Force Agreement" means that certain Confidential Agreement for Tetrachlorvinphos Data Call-In Cost Sharing, dated as of December&nbsp;7, 2001, between The Hartz
Mountain Corporation and Seller. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Technical
Rabon Insecticide Inventory" has the meaning specified in Section&nbsp;2.2. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kg1017_article_2_purchase_and_sale_of_assets"> </A>
<A NAME="toc_kg1017_3"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 2<BR>  PURCHASE AND SALE OF ASSETS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Purchased Assets.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Upon the terms set forth in this Agreement, at the Closing, the
Seller shall sell, assign, transfer, deliver and convey to the Buyer, and the Buyer shall purchase, free and clear of any Encumbrances other than Permitted Encumbrances, assets and rights described
particularly on </FONT><FONT SIZE=2><I>Schedule&nbsp;2.1</I></FONT><FONT SIZE=2> hereto (collectively, the "Purchased Assets"). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Excluded Assets.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Purchased Assets shall not include the following (collectively,
the "Excluded Assets"): </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Any
of the assets or rights described particularly on </FONT><FONT SIZE=2><I>Schedule&nbsp;2.2</I></FONT><FONT SIZE=2> hereto; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;All
Real Property; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;All
cash and Accounts Receivable; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;All
finished Rabon Products inventory ("Finished Rabon Inventory"), and all technical Rabon insecticide inventory with tetrachlorvinphos as the active ingredient
("Technical Rabon Insecticide Inventory"); </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;All
Permits held by Seller to the extent listed on </FONT><FONT SIZE=2><I>Schedule&nbsp;2.2</I></FONT><FONT SIZE=2> or </FONT> <FONT SIZE=2><I>Schedule&nbsp;5.7(b)</I></FONT><FONT SIZE=2>; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;All
raw materials, work-in-process, and finished product inventory relating to the Ravap E.C. Livestock, Poultry&nbsp;&amp; Premise Insecticide
Spray; and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;The
claims and rights under all contracts to which the Seller is a party not assigned to and assumed by the Buyer hereunder and, in the case of the Ordinary Course
Agreements, claims and rights thereunder to the extent, but only to the extent, that such claims and rights accrue prior to Closing. Notwithstanding the foregoing, any claims or rights of the Seller
under warranties relating to the Purchased Assets given by third parties shall be considered a Purchased Asset, to the extent transferable; and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;The
trademark "Ravap&#153;." </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Assumed Liabilities.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Subject to Section&nbsp;2.4, the Buyer shall assume the
rights and obligations of the Seller under the express written terms of the TCVP Task Force Agreement and certain other agreements and customer purchase orders to which Seller is a party as described
on </FONT><FONT SIZE=2><I>Schedule&nbsp;2.3</I></FONT><FONT SIZE=2> (the "Ordinary Course Agreements"). Notwithstanding the foregoing, the Ordinary Course Agreements other than the TCVP Task Force
Agreement shall be assumed by the Buyer to the extent and only to the extent the duties and obligations thereunder accrue on or after the date of Closing, excluding any Retained Liabilities
(collectively, the "Assumed Liabilities"). Buyer shall assume all rights and obligations of Seller under the TCVP Task Force Agreement, whenever accrued, and Seller shall pay for and perform, on
behalf of Buyer, all of the obligations of the Seller that would have been due or deliverable from Seller prior to the date of Closing in accordance with the TCVP Agreement as if the same had not been
assigned to Buyer hereunder. Without limiting the Seller's obligations with respect to its representations and warranties under Article&nbsp;5, the Seller shall not retain or take responsibility for
the following with respect to the Purchased Assets: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;All
accounts payable that arise subsequent to the Closing; </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=7,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=753606,FOLIO='4',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kg1017_1_5"> </A>
<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Any
liability or obligation for any and all taxes of, or pertaining or attributable to, (i)&nbsp;the Buyer for any period that begins immediately after the Closing, or
(ii)&nbsp;the Business and/or the Purchased Assets for any period beginning immediately after the Closing (including, but in no way limited to, any and all taxes described in clauses (i)&nbsp;and
(ii)&nbsp;of this Section&nbsp;2.3(b)) for which liability is or may be sought to be imposed on the Seller under any successor liability, transferee liability or similar provision of any
applicable federal, foreign, state or local law; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Liabilities
or obligations of the Seller or any of its Affiliates under any note, bond or other instrument; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Any
defects in products manufactured and sold after the Closing by the Buyer or any liability or obligation of the Buyer in respect of any express or implied
representation, warranty, agreement or guaranty made (or claimed to have been made) by the Buyer or any of its Affiliates or imposed or asserted to be imposed by operation of law (except obligations
or liabilities imposed on the Seller by operation of law after the Closing), provided that this Section&nbsp;2.3(d) shall not affect any obligations of the Seller under the Contract Manufacturing
Agreement; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;Any
obligation of the Buyer (including indemnification and other contingent obligations) relating to (i)&nbsp;acts or omissions by Buyer subsequent to the Closing,
(ii)&nbsp;goods or services provided to or for the benefit of the Buyer subsequent to the Closing, (iii)&nbsp;goods or services provided by or on behalf of Buyer or any of its licensees subsequent
to the Closing, or (iv)&nbsp;any pending or threatened Proceedings or Claims made or threatened subsequent to the Closing, to the extent related to acts or omissions of Buyer subsequent to the
Closing, including without limitation any liability arising out of the payment or non-payment of worker's compensation premiums on behalf of employees of the Business or other issues
arising out of the coverage of such employees with respect to worker's compensation insurance arising during any period subsequent to the Closing; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;Any
statutory liens accrued after the Closing against the Purchased Assets; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;Any
violation by the Buyer of, or default by the Buyer under, any Legal Requirements, including, without limitation, Applicable Environmental Laws, which imposes any
obligation or liability on Buyer, or any remedial obligation of Buyer under any Applicable Environmental Law arising out of or related to the ownership or operation of the Purchased Assets subsequent
to the Closing; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;Any
liability resulting from or relating to the employment relationship subsequent to the Closing between the Buyer or its Affiliates and any of the current employees of
the Business or the termination of any such employment relationship with the Buyer or any of its Affiliates, including, without limitation, accrued severance pay and other similar benefits, if any,
and any claim filed subsequent to the Closing or which may thereafter be filed by or on behalf of any current employee of the Business relating to the employment or termination of employment of any
such employee by the Buyer or its
Affiliates arising from the Buyer or its Affiliates acts or omissions subsequent to the Closing, including, but not limited to, any claim for wrongful discharge, breach of contract, unfair labor
practice, employment discrimination, unemployment compensation or workers' compensation subsequent to the Closing; or </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Any
liabilities or obligations of the Buyer arising from or incurred in connection with the negotiation, preparation or execution of this Agreement or the transactions
contemplated hereby, including fees and expenses of counsel. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Limitation of Liabilities.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in Section&nbsp;2.3, the
Buyer does not assume and is not in any way liable or responsible for any liabilities or obligations of the Seller; it being expressly acknowledged that it is the intention of the parties hereto that
all liabilities that the Seller has or may have in the future, whether fixed or contingent, and whether known or unknown, not expressly described in the definition of Assumed Liabilities shall be
"Retained Liabilities" and remain the </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=5,SEQ=8,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=507516,FOLIO='5',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kg1017_1_6"> </A>

<P><FONT SIZE=2>
liabilities of the Seller. Without limiting the generality of the foregoing, except to the extent specifically provided in Section&nbsp;2.3, the Buyer shall not assume, or take responsibility for: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;All
accounts payable as of the Closing; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Any
liability or obligation for any and all taxes of, or pertaining or attributable to, (i)&nbsp;the Seller for any period that ends on or before, or includes, the
Closing, or (ii)&nbsp;the Business and/or the Purchased Assets for any period or portion thereof that ends on or before the Closing (including, but in no way limited to, any and all taxes described
in clauses (i)&nbsp;and (ii)&nbsp;of this Section&nbsp;2.4(b)) for which liability is or may be sought to be imposed on the Buyer under any successor liability, transferee liability or similar
provision of any applicable federal, foreign, state or local law; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Liabilities
or obligations of the Seller or any of its Affiliates under any note, bond or other instrument; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Any
defects in products manufactured and sold prior to the Closing by the Seller or any liability or obligation of the Seller in respect of any express or implied
representation, warranty, agreement or guaranty made (or claimed to have been made) by the Seller or any of its Affiliates or imposed or asserted to be imposed by operation of law (except obligations
or liabilities imposed on the Buyer by operation of law after the Closing) provided that this Section&nbsp;2.4(d) shall not affect any obligations of the Buyer under the Contract Manufacturing
Agreement; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;Any
obligation of the Seller (including indemnification and other contingent obligations) relating to (i)&nbsp;acts or omissions by Seller existing at or prior to the
Closing, (ii)&nbsp;goods or services provided to or for the benefit of the Seller prior to the Closing, (iii)&nbsp;goods or services provided by or on behalf of the Seller or any of its licensees
prior to the Closing, or (iv)&nbsp;any pending or threatened Proceedings or Claims made or threatened prior to the Closing, to the extent related to acts or omissions of Seller prior to the Closing,
including without limitation any liability arising out of the payment or non-payment of worker's compensation premiums on behalf of employees of the Seller or other issues arising out of
the coverage of the Seller's employees with respect to worker's compensation insurance arising during any period prior to the Closing; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;Any
statutory liens accrued or existing at the time of the Closing against the Purchased Assets; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;Any
violation by the Seller of, or default by the Seller under, any Legal Requirements, including, without limitation, Applicable Environmental Laws, which affects the
ownership or operation of the Purchased Assets or results in any change in the Assumed Liabilities, or any remedial obligation under any Applicable Environmental Law arising out of or related to the
ownership or operation of the Purchased Assets prior to the Closing; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;Any
liability resulting from or relating to the employment relationship between the Seller or its Affiliates and any of their present or former employees or the
termination of any such employment relationship with the Seller or any of its Affiliates, including, without limitation, accrued severance pay and other similar benefits, if any, and any claim filed
on or prior to the Closing or which may thereafter be filed by or on behalf of any employee or former employee of the Seller or its Affiliates relating to the employment or termination of employment
of any such employee by the Seller or its Affiliates, including, but not limited to, any claim for wrongful discharge, breach of contract, unfair labor practice, employment discrimination,
unemployment compensation or workers' compensation on or prior to the Closing; or </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=6,SEQ=9,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=109419,FOLIO='6',FILE='DISK012:[03HOU7.03HOU1017]KG1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<UL>
<BR>
</UL>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_ki1017_1_7"> </A> </FONT></P>

<!-- TOC_END -->
<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Any
liabilities or obligations of the Seller arising from or incurred in connection with the negotiation, preparation or execution of this Agreement or the transactions
contemplated hereby, including fees and expenses of counsel. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Delivery.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;At Closing or as directed otherwise by the Buyer, the Seller shall deliver
to the Buyer all Rabon Records. The Seller, however, shall be entitled to retain the Common Records. The Buyer and its authorized representatives shall have the right to inspect and, at the Buyer's
expense, to copy the Common Records at any reasonable time during regular business hours for any proper purpose. For a period of seven (7)&nbsp;years following the date hereof, the Seller agrees
that it will not destroy any of the Common Records without having first offered to deliver the same to the Buyer. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ki1017_article_3_purchase_price"> </A>
<A NAME="toc_ki1017_1"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 3<BR>  PURCHASE PRICE    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Consideration for the Purchased Assets.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this
Agreement, the aggregate purchase price for the Purchased Assets (the "Purchase Price") shall be $3,820,000.00 in cash, subject to any adjustments pursuant to Section&nbsp;3.3. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Allocation of Purchase Price.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Purchase Price shall be allocated among the
Purchased Assets in the manner specified on </FONT><FONT SIZE=2><I>Schedule&nbsp;3.2</I></FONT><FONT SIZE=2> hereto (which Schedule shall be completed within 15&nbsp;days following the Closing).
The Seller and the Buyer shall cooperate with each other in the preparation, execution and filing of (a)&nbsp;all information returns and supplements thereto required to be filed with the Internal
Revenue Service by the parties under Section&nbsp;1060 of the Internal Revenue Code of 1986, as amended, and the Treasury Regulations promulgated thereunder relating to the allocation of the
Purchase Price and (b)&nbsp;all similar filings required to be filed with respect to the transactions contemplated by this Agreement with the Internal Revenue Service and other appropriate taxing
authorities. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Certain Pro-rations.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Seller shall receive a credit, on a dollar for
dollar basis as reflected on Schedule&nbsp;3.3. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ki1017_article_4_closing"> </A>
<A NAME="toc_ki1017_2"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 4<BR>  CLOSING    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Closing.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Closing will take place at the offices of Haynes and Boone, L.L.P.,
legal counsel for the Buyer, located at 1000 Louisiana, Suite 4300, Houston, Texas 77002, at 3:00&nbsp;p.m. (local time) on the date of this Agreement (the "Closing"). </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Deliveries by the Seller.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;At Closing, the Seller shall hereby deliver to the Buyer
the following: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Certificate
of the Secretary of State of the State of Delaware, dated not more than fifteen (15)&nbsp;days prior to the Closing, attesting to the due organization and
good standing of the Seller as a corporation in its jurisdiction of incorporation; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Copies,
certified by an executive officer of the Seller as of the Closing, of the certificate of incorporation of the Seller, and all amendments thereto; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Copies,
certified by an executive officer of the Seller as of the Closing, of resolutions duly adopted by the board of directors and the shareholders of the Seller, if
required, authorizing the execution and delivery by the Seller of this Agreement and all other agreements contemplated herein, the consummation the transactions contemplated herein, and the taking of
all such other corporate action as shall have been required as a condition to, or in connection with the consummation of the contemplated transactions; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Executed
counterparts of a Bill of Sale, General Conveyance, Transfer and Assignment, substantially in the form attached hereto as </FONT> <FONT SIZE=2><I>Exhibit&nbsp;A</I></FONT><FONT SIZE=2> (the "General Conveyance"), and an </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=10,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=591889,FOLIO='7',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ki1017_1_8"> </A>
<UL>
<BR>

<P><FONT SIZE=2>
Assumption Agreement, substantially in the form attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;B</I></FONT><FONT SIZE=2> (the "Assumption Agreement"), together with the Rabon Products and
Ravap Products registration transfers with the EPA in the forms attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;C</I></FONT><FONT SIZE=2>; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;Executed
counterparts of the agreement providing for the manufacture of certain of the Rabon Products by Seller and purchase of Finished Rabon Inventory and Technical
Rabon Insecticide Inventory, substantially in the form attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;D</I></FONT><FONT SIZE=2> (the "Contract Manufacturing Agreement"); </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;An
opinion of Armstrong Teasdale, legal counsel to the Seller as to those matters described in </FONT><FONT SIZE=2><I>Exhibit&nbsp;E</I></FONT><FONT SIZE=2>, subject
to customary qualification provisions; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;Executed
counterparts of the Consent, Subordination and Agreement in the form attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;I</I></FONT><FONT SIZE=2> (the
"Subordination Agreement"); and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;Executed
counterparts of the Assignment, Assumption and Consent Agreement among Buyer, Seller and The Hartz Mountain Corporation in the form attached hereto as </FONT> <FONT SIZE=2><I>Exhibit&nbsp;J</I></FONT><FONT SIZE=2> (the "Hartz Consent"). </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Deliveries by the Buyer.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;At Closing, the Buyer shall hereby deliver the following to
the Seller: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Certificate
of the Secretary of State of the State of Delaware, dated not more than fifteen (15)&nbsp;days prior to the Closing, attesting to the due organization and
good standing of the Buyer as a corporation in its jurisdiction of incorporation; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Executed
counterparts each of the Assumption Agreement and Contract Manufacturing Agreement; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;A
certificate, dated the Closing, from Buyer's Secretary as to true and certified copies of Buyer's organizational documents and the authority and the incumbency of all
officers executing this Agreement and the documents contemplated herein on behalf of Buyer; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Copies,
certified by an executive officer of the Buyer as of the Closing, of resolutions duly adopted by the board of directors, authorizing the execution and delivery
by the Seller of this Agreement and all other agreements contemplated herein, the consummation of the transactions contemplated herein, and the taking of all such other corporate action as shall have
been required as a condition to, or in connection with the consummation of the contemplated transactions; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;An
opinion of Haynes and Boone LLP, legal counsel to the Buyer, as to those matters described in </FONT><FONT SIZE=2><I>Exhibit&nbsp;F</I></FONT><FONT SIZE=2>,
subject to customary qualifications; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;Executed
counterparts of the Subordination Agreement and Hartz Consent; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;A
guaranty of KMG Chemicals,&nbsp;Inc. for the indemnification obligations of Buyer under this Agreement and the payment and performance obligations of Buyer under the
Contract Manufacturing Agreement in the form attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;K</I></FONT><FONT SIZE=2>; and </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;Cash
in the amount of $3,820,000.00, as adjusted pursuant to Section&nbsp;3.3, to the Seller in accordance with the following wire transfer instructions: </FONT></P>

<UL>
<UL>

<P><FONT SIZE=2><B>[***]</B></FONT></P>

</UL>
</UL>
</UL>
<P ALIGN="CENTER"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=11,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=385011,FOLIO='8',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ki1017_1_9"> </A>
<UL>
<UL>
</UL>
</UL>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ki1017_article_5_representatio__ki102215"> </A>
<A NAME="toc_ki1017_3"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 5<BR>  REPRESENTATIONS AND WARRANTIES OF<BR>  THE SELLER    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Seller hereby represents and warrants to the Buyer as follows: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Organization and Existence.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Seller is a corporation, duly organized, validly
existing and in good standing under the laws of the State of Delaware, with all necessary corporate power and authority to own the Purchased Assets and to carry on the Business. The Seller is duly
qualified or licensed to transact business as a foreign corporation and is in good standing in all jurisdictions in the United States in which the character of the Purchased Assets or the nature of
the Business currently conducted by it requires it to be so qualified or licensed unless the failure to so qualify or be licensed would not reasonably be expected to have a Seller MAE. Seller does not
own, directly or indirectly, any capital stock or other interest in any corporation, partnership, joint venture or other entity that has an ownership interest in the Purchased Assets. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Authority.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Seller has all necessary corporate power and authority to execute,
deliver, and perform this Agreement and the other agreements and instruments to be executed and delivered by it in connection with the transactions contemplated hereby and thereby, has taken all
necessary action to authorize the execution and delivery of this Agreement and such other agreements and instruments and the consummation of the transactions contemplated hereby and thereby. This
Agreement is, and the other agreements and instruments to be executed and delivered by the Seller in connection with the transactions contemplated hereby shall be, the legal, valid, and binding
obligations of the Seller, enforceable in accordance with their terms, except to the extent the enforceability hereof and thereof may be limited by bankruptcy, insolvency, moratorium, reorganization
or other laws relating to or affecting creditors' rights generally or by general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;No Violations.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by the Seller, the
fulfillment of and compliance by it with the terms and conditions hereof and the consummation of the transactions by it contemplated hereby will not: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Violate
any of the provisions of the Seller's certificate of incorporation or bylaws, or any agreement to which the Seller is a party; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;(i)&nbsp;Result
in a breach of or constitute a default under (whether with notice or the lapse of time or both) any Ordinary Course Agreement or any note, bond,
mortgage, loan agreement, indenture or other instrument evidencing borrowed money to which the Seller is a party or by which the Seller is bound or to which any of the Purchased Assets is subject
which breach or default would reasonably be expected to have a Seller MAE or (ii)&nbsp;result in the creation of any Encumbrance on any of the Purchased Assets, or otherwise give any Person the
right to terminate any Ordinary Course Agreement or other agreements assumed by the Buyer; or </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;To
the Seller's Knowledge, violate any provision of any law, statute, rule or administrative regulation or any judgment, order, injunction or decree of any Governmental
Entity applicable to or binding upon the Seller, or the Purchased Assets. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Governmental Approval.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in </FONT> <FONT SIZE=2><I>Schedule&nbsp;5.4</I></FONT><FONT SIZE=2>, no consent, approval, waiver, order or
authorization of, or registration, declaration or filing with, any Governmental Entity is
required to be obtained or made in connection with the execution and delivery of this Agreement by the Seller or the consummation by the Seller of the transactions contemplated hereby. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Seller Proceedings.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Except
as set forth in </FONT><FONT SIZE=2><I>Schedule&nbsp;5.5(a)</I></FONT><FONT SIZE=2>, there are no Proceedings pending, instituted or, to the Knowledge of the
Seller, threatened against the Seller and relating to the Business or the </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=12,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=232914,FOLIO='9',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ki1017_1_10"> </A>
<UL>

<P><FONT SIZE=2>
Purchased Assets or that challenges or seeks injunctive relief with respect to the transactions contemplated by this Agreement; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Except
as set forth in </FONT><FONT SIZE=2><I>Schedule&nbsp;5.5(b)</I></FONT><FONT SIZE=2>, Seller is not subject to any judicial or administrative judgment, order,
decree or restraint currently affecting the Business or the Purchased Assets. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.6</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;No Brokers.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except for Brakke Consulting,&nbsp;Inc., the Seller has not employed
or authorized anyone to represent it as a broker or finder in connection with the transactions contemplated by this Agreement, and no broker or other Person is entitled to any commission or finder's
fee from the Seller in connection with such transactions. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.7</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Ownership of Purchased Assets.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Except
with respect to the Marks and as set forth in </FONT><FONT SIZE=2><I>Schedule&nbsp;5.7(a)</I></FONT><FONT SIZE=2> hereto, the Seller owns good and marketable
title to the Purchased Assets, free and clear of all Encumbrances except for Permitted Encumbrances, and, upon the Seller's execution and delivery of this Agreement and the General Conveyance, the
Buyer will own good and marketable title to the Purchased Assets, free and clear of all Encumbrances except for Permitted Encumbrances. Except as set forth in </FONT> <FONT SIZE=2><I>Schedule&nbsp;5.7(a)</I></FONT><FONT SIZE=2>, no Affiliate of
Seller owns any part of the Purchased Assets (including without limitation the Rabon Records). The tangible
Purchased Assets (i)&nbsp;are in good operating condition and repair, subject to ordinary wear and tear, and have been maintained in accordance with standard industry practice, and (ii)&nbsp;are
capable of being used in the Business as presently being conducted without present need for repair or replacement except in the ordinary course of the Business; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Except
as set forth in </FONT><FONT SIZE=2><I>Schedule&nbsp;5.7(b)</I></FONT><FONT SIZE=2> and for the Excluded Assets, the Purchased Assets constitute all of the
assets (whether real or personal, tangible or intangible) of the Seller that are used primarily in the Business. In furtherance of the foregoing, </FONT> <FONT SIZE=2><I>Schedule&nbsp;2.1</I></FONT><FONT SIZE=2> describes all of the following, to the
extent related solely and directly to the Business: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;All
equipment, machinery, tools, appliances, implements, spare parts, supplies, and all other tangible personal property of every kind and description, together with any
rights or claims of the Seller arising out of the breach of any express or implied warranty by the manufacturers or sellers of any such assets; all inventories, purchased parts, shipping containers
and supplies, whether in the possession of the Seller, in the possession of third parties, or in transit to or from the Seller; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;All
customer and vendor lists, including all available names, addresses and telephone numbers; </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;All
registered and unregistered trademarks, including all of the Seller's rights to (i)&nbsp;the name "Rabon" and all derivatives thereof, (ii)&nbsp;all service
marks, logos, corporate names, and trade names, with respect to the name "Rabon" and all derivatives thereof (iii)&nbsp;all related goodwill, and (iv)&nbsp;all other intellectual property rights
and other intangible assets, including but not limited to all efficacy, toxicology, residue, health and environmental data and studies relating to tetrachlorvinphos and any data compensation rights in
respect thereto (clauses (i), (ii)&nbsp;and (iii), collectively, the "Marks" and, with clause&nbsp;(iv), collectively, the "Proprietary Rights"); </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;&nbsp;All
of the documentation and other materials, and all Seller's rights thereto, associated with the Proprietary Rights, including without limitation, all manufacturing
and product designs, specifications, processes and documentation, product labels, technical information and all copyrights thereto; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;&nbsp;All
Rabon Records; and </FONT></P>

</UL>
</UL>
<P ALIGN="CENTER"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=13,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=707395,FOLIO='10',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ki1017_1_11"> </A>
<UL>
<UL>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;&nbsp;The
Permits (including without limitation Permits for the Rabon Products with the EPA, along with any similar registrations under applicable state law) and other
authorizations and applications therefor. </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.8</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Environmental Matters.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Except
as set forth on </FONT><FONT SIZE=2><I>Schedule&nbsp;5.8(a)</I></FONT><FONT SIZE=2> or as reflected in the Rabon Records, the Seller has received no written
notice of any investigation or inquiry by any Governmental Entity under any Applicable Environmental Laws relating to the Business or the ownership or operation of the Purchased Assets. Except as set
forth on </FONT><FONT SIZE=2><I>Schedule&nbsp;5.8(a)</I></FONT><FONT SIZE=2> hereto, no condition exists with respect to the Business or on any of the Purchased Assets which would subject the
Seller or the Purchased Assets to any remedial obligations under any Applicable Environmental Laws. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Except
as to matters that would not constitute a Seller MAE and only with respect to the operation of the Business or ownership of the Purchased Assets since
January&nbsp;1, 1996, the Seller has obtained and been in compliance with all of the material terms and conditions of all Permits required under, and has complied with all other limitations,
restrictions, conditions, standards, prohibitions, requirements, obligations, schedules, and timetables which are contained in, all Applicable Environmental Laws. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Except
as set forth on </FONT><FONT SIZE=2><I>Schedule&nbsp;5.8(c)</I></FONT><FONT SIZE=2>, the Seller has not caused or allowed the generation, use, treatment,
storage or disposal of Hazardous Materials at the Facility, except in accordance with all Applicable Environmental Laws or except to the extent the same would not have a Seller MAE. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Except
as set forth on </FONT><FONT SIZE=2><I>Schedule&nbsp;5.8(d)</I></FONT><FONT SIZE=2>, the Seller has not received any written notice from any Governmental
Entity regarding (A)&nbsp;any actual, alleged, possible or potential violation of or failure to comply with any term or requirement of any Permit, necessary to operate the Business or the Purchased
Assets that pertains to Applicable Environmental Laws or (B)&nbsp;any actual, proposed, possible or potential revocation, withdrawal, suspension, cancellation, termination of or modification to any
such Permit. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;Except
for Permits related to the Business, the Seller is not currently operating or required to be operating any of the Purchased Assets under any compliance order,
schedule, decree or agreement, any consent decree, order or agreement, or corrective action decree, order or agreement issued or entered into under any Environmental Law. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;For
purposes of this Agreement, "Applicable Environmental Laws" means any and all Legal Requirements pertaining to (x)&nbsp;the control of any potential pollutant or
protection of the air, water or land, (y)&nbsp;solid, gaseous or liquid waste generation, handling, treatment, storage, disposal or transportation, or (z)&nbsp;exposure to hazardous, toxic or
other substances alleged to be harmful. Applicable "Environmental Laws" shall include all such laws in effect in any and all jurisdictions in which the Purchased Assets are located or in which any
Seller or its Affiliates has conducted operations using any of the Purchased Assets, including, without limitation, the Clean Air Act, as amended, the Comprehensive Environmental Response,
Compensation and Liability Act of 1980, as amended, the Rivers and Harbors Act of 1899, as amended, the Federal Water Pollution Control Act, as amended, the Occupational Safety and Health Act of 1970,
as amended, the Resource Conservation and Recovery Act of 1976, as amended, the Safe Drinking Water Act, as amended, the Toxic Substances Control Act, as amended, the Superfund Amendments and
Reauthorization Act of 1986, as amended, the Hazardous Materials Transportation Act, Fungicide Rodenticide Act, as amended, the Food Quality Product Act, as amended, and other environmental
conservation or protection laws. For purposes of this Agreement, the term "Hazardous Material" means (i)&nbsp;any substance which is listed or defined as a hazardous substance, </FONT></P>

</UL>
<P ALIGN="CENTER"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=5,SEQ=14,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=117650,FOLIO='11',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_ki1017_1_12"> </A>
<UL>
<BR>

<P><FONT SIZE=2>
hazardous constituent, or solid waste pursuant to any Applicable Environmental Laws and (ii)&nbsp;petroleum (including crude oil and any fraction thereof), natural gas and natural gas liquids. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.9</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Compliance With Laws.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except as would not have a Seller MAE and only with respect to
operations of the Business or the ownership of the Purchased Assets: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;The
Seller is, and at all times since January&nbsp;1, 1996 has been, in compliance with each law, rule, regulation, code, governmental determination, order,
governmental certification requirement or other public limitation (collectively, "Legal Requirements"); </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;No
event has occurred or circumstance exists that (with or without notice or lapse of time) may constitute or result in a violation by Seller of, or a failure on the
part of Seller to comply with, any Legal Requirement; and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Within
the two (2)&nbsp;years preceding the date of Closing, Seller has not received any notice or other communication (written or otherwise) from any Governmental
Entity regarding any actual, alleged, possible or potential violation of, or failure to comply with, any applicable Legal Requirement. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.10</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Permits.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;To the extent related to the Business or the ownership of the Purchased
Assets, </FONT><FONT SIZE=2><I>Schedule&nbsp;5.10</I></FONT><FONT SIZE=2> sets forth all of the Permits issued, granted, given, or otherwise made available by or under the authority of any
Governmental Entity or pursuant to any Legal Requirement and each such Permit is valid and in full force and effect. No event has occurred or circumstance exists that (with or without notice or lapse
of time) (A)&nbsp;constitutes a violation of or a failure to comply with any term or requirement of any Permit or (B)&nbsp;will result in the revocation, withdrawal, suspension, cancellation or
termination of, or any modification to any Permit. All applications required to have been filed for the renewal of the Permits have been duly filed on a timely basis with the appropriate Governmental
Entity, and all other filings required to have been made with respect to such Permits have been duly made on a timely basis with the appropriate Governmental Entity. The Permits listed in </FONT> <FONT SIZE=2><I>Schedule&nbsp;5.10</I></FONT><FONT
SIZE=2> collectively constitute all of the material Permits necessary to permit Seller to lawfully conduct and operate the Business in the
manner in which it currently conducts and operates the Business and to permit Seller to own, maintain and use the Purchased Assets in the manner in which it currently owns, maintains and uses such
Purchased Assets. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=6,SEQ=15,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=791089,FOLIO='12',FILE='DISK012:[03HOU7.03HOU1017]KI1017A.;4',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_kk1017_1_13"> </A> </FONT></P>

<!-- TOC_END -->

<P><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.11</FONT><FONT SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;True
and correct copies of the unaudited statements of sales revenue, volume and gross profit for Rabon Products (by product) for the two years ended December&nbsp;31,
2000 and 2001, and an interim statement of sales revenue, volume and gross profit as of October&nbsp;31, 2002 (collectively, the "Seller Financial Statements"), have been previously delivered to the
Buyer. The Seller Financial Statements fairly present, in accordance with generally accepted accounting principles consistently applied, in all material respects the sales, volume and gross profit of
the Seller for Rabon Products for the periods covered thereby. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Except
as set forth in </FONT><FONT SIZE=2><I>Schedule&nbsp;5.11(b)</I></FONT><FONT SIZE=2>, since December&nbsp;31, 2001, to the extent related to the Business
there has not been (i)&nbsp;to the Knowledge of Seller, any Seller MAE, or (ii)&nbsp;any sale, lease or other disposition by the Seller of any assets or any interests therein, or entering into any
agreement by the Seller granting to any third person a right to purchase, lease or otherwise acquire any assets or interests therein. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.12</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Intangible Assets.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;There are no pending or, to the Knowledge of the Seller,
threatened infringement claims against the Seller by any Person with respect to any of the Proprietary Rights. Except as set forth on </FONT> <FONT SIZE=2><I>Schedule&nbsp;5.12</I></FONT><FONT SIZE=2> and except with respect to the Marks, the
Proprietary Rights will afford the Buyer at all times after the Closing the rights to use
all technology, proprietary information, know-how or patented ideas, designs, inventions, trademarks, copyrights, tradenames and service marks owned by the Seller to the extent used solely
and directly in the conduct of the Business as presently being conducted. To the Seller's Knowledge, the use of the Proprietary Rights (exclusive of the Marks) does not and the conduct of the Business
as presently conducted does not, infringe on the rights of any other Person. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.13</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Instruments in Full Force and Effect.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Ordinary Course Agreements and other
material commitments, agreements and obligations (including without limitation licenses, royalties, assignments and similar agreements with respect to the Proprietary Rights) constituting a part of
the Purchased Assets (the "Instruments") are valid, binding and in full force and effect, have not been amended or supplemented in any manner or respect except as disclosed, and upon assignment and
assumption, with applicable consents if necessary, will be enforceable by the Buyer in accordance with their respective terms. There are no defaults by the Seller thereunder and to the Seller's
Knowledge there are no defaults thereunder by any other party thereto, and, to the Seller's Knowledge, no event has occurred that with the lapse of time or action or inaction by any party thereto
would result in a violation thereof or a default thereunder. None of the rights under the Instruments will be impaired by the
consummation of the transactions contemplated by this Agreement, and all such rights will inure to and be enforceable by the Buyer after the Closing without the authorization, consent, approval,
permit or licenses of, or filing with, any other Person. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.14</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Disclaimer of other Representations and Warranties.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly set forth
in this Article&nbsp;5, the Seller makes no representation or warranty, express or implied, at law or in equity, in respect of any of its assets (including, without limitation, the Purchased
Assets), businesses, liabilities or operations, including, without limitation, with respect to merchantability or fitness for any particular purpose, and any such other representations or warranties
are hereby expressly disclaimed. Buyer hereby acknowledges and agrees that, except to the extent specifically set forth in this Article&nbsp;5, the Buyer is purchasing the Purchased Assets on an
"as-is" basis. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=16,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=902100,FOLIO='13',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_14"> </A>
<BR>
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kk1017_article_6_representations_and_warranties_of_the_buyer"> </A>
<A NAME="toc_kk1017_1"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 6<BR>  REPRESENTATIONS AND WARRANTIES OF THE BUYER    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Buyer hereby represents and warrants to the Seller as follows: </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Organization and Existence.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Buyer is a corporation, duly organized, validly
existing and in good standing under the laws of the State of Texas, with all necessary corporate power and authority to own the Purchased Assets and to carry on the Business. The Buyer is duly
qualified or licensed to transact business as a foreign corporation and is in good standing in all jurisdictions in the United States in which the character or the nature of the business currently
conducted by it requires it to be so qualified or licensed unless the failure to so qualify or be licensed would not reasonably be expected to have a material adverse effect. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Authority.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Buyer has all necessary corporate power and authority to execute,
deliver, and perform this Agreement and the other agreements and instruments to be executed and delivered by it in connection with the transactions contemplated hereby and thereby, has taken all
necessary action to authorize the execution and delivery of this Agreement and such other agreements and instruments and the consummation of the transactions contemplated hereby and thereby. This
Agreement is, and the other agreements and instruments to be executed and delivered by the Buyer in connection with the transactions contemplated hereby shall be, the legal, valid, and binding
obligations of the Buyer, enforceable in accordance with their terms, except to the extent the enforceability hereof and thereof may be limited by bankruptcy, insolvency, moratorium, reorganization or
other laws relating to or affecting creditors' rights generally or by general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;No Violations.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery of this Agreement by the Buyer, the
fulfillment of and compliance by it with the terms and conditions hereof and the consummation by it of the transactions contemplated hereby will not: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Violate
any of the terms of the Buyer's articles of incorporation or bylaws, or any agreement to which the Buyer is a party; </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Result
in a breach of or constitute a default under (whether with notice or the lapse of time or both) any note, bond, mortgage, loan agreement, indenture or other
instrument evidencing borrowed money to which the Buyer is a party or by which the Buyer is bound or to which any of its assets is subject or result in the creation of any Encumbrance on any of its
assets, which breach or default would reasonably be expected to have a material adverse effect on the Buyer's business or financial condition or the results of its operations or on its ability to
perform its obligations hereunder; or </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;To
the Buyer's Knowledge, violate any provision of any law, statute, rule or administrative regulation or any judgment, order, injunction or decree of any Governmental
Entity applicable to or binding upon the Buyer or any of its subsidiaries. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Governmental Approval.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No consent, approval, waiver, order or authorization of, or
registration, declaration or filing with, any Governmental Entity is required to be obtained or made in connection with the execution and delivery, of this Agreement by the Buyer or the consummation
by the Buyer of the transactions contemplated herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Buyer Proceedings.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;There are no Proceedings, suits or investigations pending,
instituted or, to the Knowledge of the Buyer threatened against the Buyer or its subsidiaries that could reasonably be expected to have a material adverse effect on the business or financial condition
of the Buyer taken as a whole or that, if adversely determined, would delay or prevent the consummation of the transactions contemplated by this Agreement. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=17,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=113788,FOLIO='14',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_15"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;No Brokers.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Buyer has not employed or authorized anyone to represent it as a
broker or finder in connection with the transactions contemplated by this Agreement, and no broker or other Person is entitled to any commission or finder's fee from the Buyer in connection with such
transactions. The Buyer will indemnify and hold harmless the Seller from and against any and all losses, claims, demands, damages, costs and expenses, including, without limitation, reasonable
attorneys' fees and expenses the Seller may sustain or incur as a result of any claim for a commission or fee by a broker or finder acting on behalf of the Buyer. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kk1017_article_7_post_closing_covenants"> </A>
<A NAME="toc_kk1017_2"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 7<BR>  POST CLOSING COVENANTS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Seller and the Buyer hereby covenant and agree as follows: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Confidentiality.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Each
party shall maintain in strict confidence all Confidential Information and disclose such Confidential Information only (A)&nbsp;to its employees and duly
authorized agents and representatives who have been informed of the obligations of the parties under this Agreement with respect to such Confidential Information, who have a need to know information
in connection with consummating the transactions contemplated herein, and who agree to keep such information confidential, or (B)&nbsp;as required by legal process (of which the other party shall be
given prompt notice). The party receiving Confidential Information (as used in this Section, "receiving party") shall be responsible for any breach of this Section&nbsp;7.1 with respect to such
Confidential Information by any of its representatives and agrees to take all reasonable measures to restrain its representatives from prohibited or unauthorized disclosure of the Confidential
Information. For the purpose of this Section&nbsp;7.1(a), the term "Confidential Information" shall mean information that (i)&nbsp;with respect to the Buyer, relates directly and solely to the
Business, the Purchased Assets, the Rabon Records or the Assumed Liabilities, and with respect to the Seller, relates directly and solely to the Common Records, and (ii)&nbsp;is the subject of
efforts that under the circumstances are reasonable to maintain its confidentiality; provided however "Confidential Information" shall not mean (A)&nbsp;information generally available to the public
which has not become available as a result of disclosure in violation of this Section&nbsp;7.1, (B)&nbsp;information which becomes available on a nonconfidential basis from a source other than the
receiving party or its representatives, provided that such source is not known by the party to this Agreement receiving such information to be bound by a confidentiality agreement or other obligation
of secrecy to another party to this Agreement or its representatives and (C)&nbsp;information that was or is developed by the receiving party independently of and solely without reference to any
Confidential Information. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;No
press release, public announcement, confirmation or other information regarding this Agreement or the contents hereof shall be made by the Buyer or the Seller without
prior consultation with the Buyer and the Seller, except as may be necessary in the opinion of counsel to any party to meet the requirements of any applicable law or regulations (including, without
limitation, disclosure requirements in connection with securities laws and regulations or exchange rules) or the determination of any court. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Expenses.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise expressly provided in this Agreement, each of the
parties hereto shall assume and bear all expenses, costs and fees incurred or assumed by such party in the preparation and execution of this Agreement and in compliance with and performance of the
agreements and covenants contained in this Agreement. Without limiting the generality of the foregoing, Seller shall be responsible and shall pay all costs and expenses associated with Brakke
Consulting,&nbsp;Inc. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Agreement to Not Compete.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In consideration of the Purchase Price, the Seller agrees
that, effective as of the date hereof and for a period of sixty (60)&nbsp;months hereafter (the "Non-Compete </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=18,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=579513,FOLIO='15',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_16"> </A>
<BR>

<P><FONT SIZE=2>
Term"), neither the Seller nor any of its Affiliates shall, without the consent of the Buyer, directly or indirectly own, engage in, manage, operate, join, control, finance or participate in the
ownership, management, operation, control or financing of, or be connected as an employer, principal, agent, representative, consultant, investor, owner (including shareholder), lender, partner,
manager, joint venturer or otherwise with, or permit its or its Affiliates' names to be used by or in connection with (i)&nbsp;the Business conducted by the Seller (except with respect to the Ravap
Products) and (ii)&nbsp;the development, manufacturing, processing, storage, distribution, sale marketing, use and licensing of oral larvicides in the United States. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Non-Interference with Relationships.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;During the Non-Compete
Term, the Seller shall not directly or indirectly, to the extent related to the Business: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;(i)&nbsp;call
upon, canvass, solicit or transact, or attempt to call upon, canvass, solicit or transact, business with any customer of the Buyer (except with respect
to the Ravap Products), or (ii)&nbsp;advise customers or suppliers of the Seller to withdraw, curtail or cancel business with the Buyer; or </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;(i)&nbsp;render
services related to the Business to or for competitors of the Buyer, or (ii)&nbsp;supply sales, financial, manufacturing, design, marketing,
engineering or technical information with respect to the Business to third parties. </FONT></P>

</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Specific Performance.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Seller acknowledges and agrees that any breach of the
restrictive covenants set forth in Sections 7.3 and 7.4 hereof will result in irreparable damage to the Buyer for which there will be no adequate remedy at law, and the Seller consents to an
injunction, issued by any court of competent jurisdiction, in favor of the Buyer, enjoining any breach of such covenant, without prejudice to any other right or remedy to which the Buyer may be
entitled. In the event that any part of Sections 7.3 and 7.4 herein is determined by any court of competent jurisdiction to be unenforceable by reason of its being extended for too great a period of
time or too large a geographic area or over too great a range of activities, that section is to be interpreted to extend only over the maximum period of time, geographic area or range of activities
required to render it valid and enforceable. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Testing Costs Reimbursement.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Seller is now responding to a Reauthorization
Eligibility Document for tetrachlorvinphos that was issued in 1995 by the EPA. A revised risk assessment that incorporated the requirements of the Food Quality Protection Act of 1996 was conducted in
1997-99. The EPA required additional residue chemistry studies on poultry, swine and cattle to confirm that residues of tetrachlorvinphos and four metabolites were at acceptable dietary
levels. These studies were requested in December&nbsp;1999. To the extent that the aggregate out-of-pocket testing cost of any residue testing incurred by Buyer as part of
satisfying such reregistration of the Rabon Products, plus any related administrative out-of-pocket costs, exceeds $250,000.00, Seller will pay for or reimburse such costs on
Buyer's behalf promptly upon receipt of an invoice from Buyer, up to an aggregate total of
$1,000,000.00, which invoice shall contain evidence that such costs were incurred and satisfied by payment to a third party. The provisions of this Section&nbsp;7.6 are not subject to the
limitations of Sections 8.6. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Subregistrations.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Immediately following the approval of the transfer to Buyer of the
registrations for the Rabon Products by the EPA, Buyer shall deliver to the Seller the executed counterpart of an agreement under which Buyer subregisters to Seller the right to sell Ravap E.C.
Livestock, Poultry&nbsp;&amp; Premise Insecticide Spray, substantially in the form attached hereto as Exhibit&nbsp;G (the "Subregistration Agreement"). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Diflubenzuron Agreement.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As soon as practicable after the Closing, Seller shall use
its commercially reasonable best efforts to take all such action as is reasonably necessary to assist Buyer without additional cost or liability to Buyer in securing the consent of Crompton Sales
Company,&nbsp;Inc. to the assignment of that certain Distribution and Formulation Agreement dated June&nbsp;1, 2001. Upon </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=19,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=228887,FOLIO='16',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_17"> </A>
<BR>

<P><FONT SIZE=2>
such consent, each of Seller and Buyer shall promptly execute and deliver the Assignment and Assumption Agreement attached hereto as </FONT><FONT SIZE=2><I>Exhibit&nbsp;H</I></FONT><FONT SIZE=2>,
which assignment shall include all data and other information developed by the parties to the Crompton Sales Agreement in connection with the performance of such agreement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.9</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Trademark License.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Seller recognizes the need to allow Buyer, during the pendency of
the transfer of Rabon Products registrations contemplated by this Agreement, to use certain trademarks of Seller as are currently included on labels of Rabon Products, including: BOEHRINGER INGELHEIM,
BOEHRINGER INGELHEIM VETMEDICA,&nbsp;INC. and related trademark designs ("BI Trademarks"). Seller hereby grants to Buyer, subject to and in compliance with all other terms and conditions of this
Agreement, a non-exclusive license to use the BI Trademarks for a period of one year following the Closing solely in connection with (i)&nbsp;printing labels that conform to the EPA
registrations for Rabon Products, and (ii)&nbsp;affixing such labels to Rabon Products that conform to the EPA registrations therefor. Upon reasonable request of Buyer, Seller will extend the term
of the license granted under this Section&nbsp;7.9 in up to two successive six-month increments with respect to Rabon Products for which the EPA has not transferred registration at the
time of such request. Buyer agrees that it will do nothing inconsistent with Seller's ownership of the BI Trademarks, and that all use of the BI Trademarks and all goodwill developed therefrom shall
inure to the benefit of and be on behalf of Seller. Buyer agrees that nothing in this clause shall give Buyer any right, title, or interest in the BI Trademarks other than the right to use the BI
Trademarks in accordance with this Section&nbsp;7.9. Buyer agrees that it will not attack the title of Seller to the BI Trademarks or attack the validity of this clause. Buyer is prohibited from
entering into any sublicenses of its rights under this Section&nbsp;7.9 to any other third party without the consent of Seller, which consent shall not be unreasonably withheld. Seller hereby
consents to the sublicense by Buyer of any and all of Buyer's rights under this Section&nbsp;7.9 to PM Resources. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kk1017_article_8_extent_and_survival___art04031"> </A>
<A NAME="toc_kk1017_3"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 8<BR>  EXTENT AND SURVIVAL OF REPRESENTATIONS,<BR>  WARRANTIES, COVENANTS AND AGREEMENTS; INDEMNIFICATION    <BR>  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification by the Seller.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Seller agrees to indemnify, defend and hold the
Buyer and its Affiliates, officers, directors, employees or agents harmless from and against any and all Claims sustained by the Buyer or any of its Affiliates based upon, arising out of or otherwise
in respect of (i)&nbsp;the inaccuracy of any representation or warranty, or the breach of any covenant or agreement, of the Seller contained in this Agreement, or (ii)&nbsp;Seller Liabilities. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification by the Buyer.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Buyer agrees to indemnify, defend and hold the
Seller and its Affiliates, officers, managers, employees or agents harmless from and against any and all Claims sustained by the Seller or any of its Affiliates based upon, arising out of or otherwise
in respect of (i)&nbsp;the inaccuracy of any representation or warranty, or the breach of any covenant or agreement, of the Buyer contained in this Agreement, or (ii)&nbsp;any of the Buyer
Liabilities. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Indemnification Procedure.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Any party seeking information or reimbursement for Claims
hereunder (the "Indemnified Party") shall as promptly as practical notify the party from which such indemnification is sought (the "Indemnifying Party") upon which the Indemnified Party intends to
base a claim for indemnification or reimbursement hereunder; provided, however, that the failure of an Indemnified Party so to notify the Indemnifying Party shall not relieve the Indemnifying Party
from any liability under this Agreement to the Indemnified Party with respect to such Claim except to the extent the Indemnifying Party is actually prejudiced or damaged by the failure to receive
timely notice. In the event of any claims for indemnification or reimbursement, the Indemnifying Party, at its option, may assume (with legal counsel reasonably acceptable to the Indemnified Party)
the defense of any claim, demand, lawsuit or other proceeding brought against the Indemnified Party, which claim, demand, lawsuit or other proceeding may give rise to the indemnity or reimbursement
obligation of the </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=5,SEQ=20,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=713782,FOLIO='17',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_18"> </A>
<BR>

<P><FONT SIZE=2>
Indemnifying Party hereunder, and may assert any defense of any party; provided, however, that the Indemnified Party shall have the right at its own expense to participate jointly with the
Indemnifying Party in the defense of any claim, demand, lawsuit or other proceeding in connection with which the Indemnified Party claims indemnification or reimbursement hereunder. Notwithstanding
the right of an Indemnified Party so to participate, the Indemnifying Party shall have the sole right to settle or otherwise dispose of such claim, demand, lawsuit or other proceeding on such terms as
the Indemnifying Party, in its sole discretion, shall deem appropriate with respect to any issue involved in such claim, demand, lawsuit or other proceeding as to which (i)&nbsp;the Indemnified
Party shall have acknowledged the obligation to indemnify the Indemnified Party hereunder and the settlement is solely for cash or (ii)&nbsp;the Indemnified Party shall have declined so to
participate. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Survival.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All representations and warranties of the parties hereto shall survive the
date hereof and shall remain in full force and effect for a period of eighteen (18)&nbsp;months, except for Sections 5.2, 5.7 and 5.8 which shall continue until the expiration of the applicable
statute of limitations. All representations, warranties and covenants and agreements made by the parties shall not be affected by any investigation heretofore or hereafter made by and on behalf of any
of them and shall not be deemed merged into any instruments or agreements delivered in connection with the transactions contemplated hereby. The covenants and agreements entered into pursuant to this
Agreement shall survive the date hereof without limitation (subject to the applicable statutes of limitations). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;APPLICABILITY OF INDEMNIFICATION OBLIGATION.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>EACH OF THE
AGREEMENTS TO INDEMNIFY, DEFEND OR HOLD HARMLESS CONTAINED IN SECTION 8.2 OR 8.3 SHALL APPLY IRRESPECTIVE OF WHETHER THE SUBJECT CLAIM IS BASED IN WHOLE OR IN PART UPON THE SOLE OR CONTRIBUTORY
NEGLIGENCE (WHETHER ACTIVE, PASSIVE OR GROSS), BREACH OF COVENANT, OR BREACH OR VIOLATION OF ANY DUTY IMPOSED BY ANY LAW OR REGULATION, ON THE PART OF THE BENEFICIARY OF THE AGREEMENT, EXCEPT AS
OTHERWISE EXPRESSLY PROVIDED IN THIS AGREEMENT.</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.6</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Limitation on Amounts.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;No Indemnified Party shall be entitled to any indemnification
until the aggregate dollar amount of all Claims suffered by the Indemnified Party reaches Fifty Thousand Dollars ($50,000.00); provided, however, that the Indemnified Party shall then be entitled only
to those amounts exceeding $50,000.00 once that amount is exceeded. Notwithstanding any other provisions contained in this Agreement, the maximum amount that may be recovered by an Indemnified Party
under this Article&nbsp;8 or otherwise shall be One Million Nine Hundred and Ten Thousand Dollars ($1,910,000.00). In no event shall this section apply to the obligations of the Buyer under
Article&nbsp;2 or Seller under Section&nbsp;7.6. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.7</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Effect of Insurance.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Any Claim for which an Indemnifying Party is liable shall be
reduced (including, without limitation, retroactively) by any insurance proceeds actually recovered that directly relate to the Claims for which indemnification is sought. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.8</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Sole Remedy.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Buyer and the Seller acknowledge and agree that in the absence of
fraud, gross negligence or intentional misconduct, the foregoing indemnification provisions in this Article&nbsp;8 shall be the sole and exclusive remedy at equity and law of the Buyer and the
Seller with respect to this Agreement, provided that this provision shall not affect the rights and remedies of the parties under the Contract Manufacturing Agreement. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="kk1017_article_9_miscellaneous"> </A>
<A NAME="toc_kk1017_4"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE 9<BR>  MISCELLANEOUS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.1</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Notices.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All notices and other communications required or permitted to be given or
made hereunder by either party hereto shall be in writing and shall be deemed to have been duly given if delivered personally or sent by prepaid overnight delivery service, or sent by facsimile
transmission, to </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=6,SEQ=21,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=577248,FOLIO='18',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_19"> </A>

<P><FONT SIZE=2>
the parties at the following addresses (or at such other addresses as shall be specified by the parties by like notice): </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
to the Buyer: </FONT></P>

<UL>
<UL>

<P><FONT SIZE=2>KMG
Bernuth,&nbsp;Inc.<BR>
10611 Harwin, Suite 402<BR>
Houston, Texas 77036<BR>
Attention: John V. Sobchak, Vice President and CFO<BR>
Facsimile: (713)&nbsp;988-9298 </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
a copy to: </FONT></P>

<UL>
<UL>

<P><FONT SIZE=2>Roger
C. Jackson, Esq.<BR>
General Counsel<BR>
KMG Chemicals,&nbsp;Inc.<BR>
10611 Harwin, Suite 402<BR>
Houston, Texas 77036<BR>
Facsimile: (713)&nbsp;988-9298 </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
to the Seller: </FONT></P>

<UL>
<UL>

<P><FONT SIZE=2>Boehringer
Ingelheim Vetmedica,&nbsp;Inc.<BR>
2621 North Belt Highway<BR>
St. Joseph, Missouri 64506-2002<BR>
Attention: Jim Kroman<BR>
Facsimile: (816)&nbsp;233-3487 </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with
a copy to: </FONT></P>

<UL>
<UL>

<P><FONT SIZE=2>Armstrong
Teasdale, LLP<BR>
One Metropolitan Square<BR>
Suite 2600<BR>
St. Louis, Missouri 63102-2740<BR>
Attention: Mark Stoneman<BR>
Facsimile: (314)&nbsp;612-2353 </FONT></P>

</UL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
notices, demands and other communications shall be effective (i)&nbsp;if delivered personally or sent by courier service, upon actual receipt by the intended receipt,
(ii)&nbsp;if mailed, upon the earlier of five days after deposit in the mail or the date of delivery as shown by the return receipt therefor, or (iii)&nbsp;if sent by telecopy or facsimile
transmission, when confirmation of receipt is received. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.2</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Agreement, including the schedules, exhibits, annexes and
other writings referred to herein or delivered pursuant hereto, constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior
agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof. This Agreement supersedes that certain letter agreement, dated November&nbsp;1,
2002. This Agreement does not, however, supersede that certain Mutual Nondisclosure Agreement, between the Buyer and Seller, dated August&nbsp;28, 2002; provided, however that Buyer shall have no
obligations under the Mutual Nondisclosure Agreement with respect to Rabon Records. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.3</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Amendments and Waiver; Rights and Remedies.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be amended,
superseded, canceled, renewed or extended, and the terms hereof may be waived, only by a written instrument signed by the parties or, in the case of a waiver, by the party waiving compliance. No delay
on the part of either party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of either party of any such right, power or
privilege, or any single or </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=7,SEQ=22,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=1007867,FOLIO='19',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_20"> </A>
<BR>

<P><FONT SIZE=2>
partial exercise of any such right, power or privilege, preclude any further exercise thereof or the exercise of any other such right, power or privilege. The rights and remedies herein provided are
cumulative and are not exclusive of any rights or remedies that any party may otherwise have at law or in equity. The rights and remedies of either party based upon, arising out of or otherwise in
respect of any inaccuracy in or breach of any representation, warranty, covenant or agreement contained in this Agreement shall in no way be limited by the fact that the act, omission, occurrence or
other state of facts upon which any claim of any such inaccuracy or breach is based may also be the subject matter of any other representation, warranty, covenant or agreement contained in this
Agreement (or in any other agreement between the parties) as to which there is no inaccuracy or breach. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.4</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Governing Law.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be governed by, and construed in accordance
with, the laws of the State of Texas, without regard to the principles of conflicts of laws thereof. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.5</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Binding Effect; Assignment.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Agreement and all the provisions hereof shall be
binding upon and inure to the benefit of the parties and their respective successors and permitted assigns. The Buyer may upon notice to the Seller direct that title to all or part of the Purchased
Assets be taken in one or more of the Buyer's wholly owned subsidiaries (direct or indirect). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.6</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Counterparts.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed simultaneously in two (2)&nbsp;or
more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.7</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;References.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;All references in this Agreement to Articles, Sections and other
subdivisions refer to the Articles, Sections and other subdivisions of this Agreement unless expressly provided otherwise. The words "this Agreement," "herein," "hereof," "hereby," "hereunder" and
words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.8</FONT><FONT
SIZE=2><B><I>&nbsp;&nbsp;&nbsp;&nbsp;Severability of Provisions.</I></B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;If any provision of this Agreement is held to be
unenforceable, this Agreement shall be considered divisible and such provision shall be deemed inoperative to the extent it is deemed unenforceable, and in all other respects this Agreement shall
remain in full force and effect; provided, however, that if any such provision may be made enforceable by limitation thereof, then such provision shall be deemed to be so limited and shall be
enforceable to the maximum extent permitted by applicable law. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>[REMAINDER OF PAGE INTENTIONALLY BLANK&#151;SIGNATURE PAGE FOLLOWS]</B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=8,SEQ=23,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=550822,FOLIO='20',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<A NAME="page_kk1017_1_21"> </A>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>IN WITNESS WHEREOF</B></FONT><FONT SIZE=2>, the parties have caused this Asset Purchase Agreement to be executed by their respective officers hereunto duly
authorized as of the date first above written. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><FONT SIZE=2><B>BUYER:</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=2><FONT SIZE=2><B>SELLER:</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=2><BR><FONT SIZE=2><B>KMG BERNUTH, INC.</B></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=2><BR><FONT SIZE=2><B>BOEHRINGER INGELHEIM VETMEDICA, INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>DAVID M. HATCHER</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>DAVID J. ROBERTS</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>David M. Hatcher, </FONT><FONT SIZE=2><I>President</I></FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=2>Name:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>David J. Roberts</FONT><HR NOSHADE></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="11%"><FONT SIZE=2>Title:</FONT></TD>
<TD WIDTH="41%"><FONT SIZE=2><I>Vice President&#151;Finance</I></FONT><HR NOSHADE></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=9,SEQ=24,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2",CHK=123104,FOLIO='21',FILE='DISK012:[03HOU7.03HOU1017]KK1017A.;8',USER='MTRAN',CD=';9-JAN-2003;13:25' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03HOU1017_2">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_kc1017_1">EXHIBIT 2.1 (iv)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_ke1017_1">TABLE OF CONTENTS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_kg1017_1">ASSET PURCHASE AGREEMENT</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_kg1017_2">ARTICLE 1 DEFINITIONS</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_kg1017_3">ARTICLE 2 PURCHASE AND SALE OF ASSETS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_ki1017_1">ARTICLE 3 PURCHASE PRICE</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ki1017_2">ARTICLE 4 CLOSING</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ki1017_3">ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF THE SELLER</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_kk1017_1">ARTICLE 6 REPRESENTATIONS AND WARRANTIES OF THE BUYER</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_kk1017_2">ARTICLE 7 POST CLOSING COVENANTS</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_kk1017_3">ARTICLE 8 EXTENT AND SURVIVAL OF REPRESENTATIONS, WARRANTIES, COVENANTS AND AGREEMENTS; INDEMNIFICATION</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_kk1017_4">ARTICLE 9 MISCELLANEOUS</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=AHANSON,SEQ=,EFW="2100203",CP="KMG CHEMICALS, INC.",DN="2" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
